City
Epaper

42 young Indian robotic surgeons set to share path-breaking procedures

By IANS | Updated: May 27, 2023 13:40 IST

Mumbai, May 27 As robotic surgeries, slowly but steadily, become mainstream in India, US-based Vattikuti Foundation is organising ...

Open in App

Mumbai, May 27 As robotic surgeries, slowly but steadily, become mainstream in India, US-based Vattikuti Foundation is organising a key seminar here next month where young robotic surgeons from across the country will share their path-breaking procedures.

India has a need for a huge pool of orthopaedic surgery super-specialists who can handle the special needs of over 10 million children with physical deformities.

Specialist orthopaedic surgeons who can treat limb and spine problems can provide a better quality of life to afflicted children who form a startling 2.2 per cent of India's young from newborns to 18-year-olds.

"India has approximately 100 paediatric orthopaedic surgeons which translates to a caseload of 5 million cases per surgeon," according to Dr Ashok K Johari, an eminent paediatric orthopaedic surgeon.

It is well known that if congenital deformities are corrected early, "a child can be given the chance to live a better life. It is easier to conduct surgeries on a child by modifying the growth of the affected part," added Dr Johari, who is also the President of the International Federation of Paediatric Societies.

Dr Johari will be in conversation with urology surgeon Dr Mahendra Bhandari, CEO of Vattikuti Foundation, on June 11 at a session with specialist surgeons who earned a one-year Vattikuti Foundation Fellowship to become accomplished robotic surgeons.

The Vattikuti Foundation has provided 51 young Indian surgeons year-long fellowships to study robotic surgery under the guidance of mentor surgeons.

At the event, 42 fellows from 18 locations across the country will share their experiences of conducting path-breaking robotic surgery procedures from head and neck, gastroenterology, general surgery, urology, gynaecology and colorectal soft tissue surgeries as well as joint replacement surgeries.

The fellows gained hands-on experience conducting surgeries at large corporate, government trust and private hospitals in India. Most fellows have also been sponsored for 2-to-4-week study programmes in the US.

"The Vattikuti Foundation is humbled by the success of its mission of training over 500 surgeons to become accomplished robotic surgeons and taking the benefits of minimally invasive surgery to patients globally," said Dr Bhandari.

Vattikuti Foundation is currently accepting submissions for the KS International Innovation Awards 2023 in memory of Krishnaswami Subramaniam who is credited with growing the installed base of surgical robots in India.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Joy-ConInternational federation of paediatric societiesMahendra BhandariKrishnaswami subramaniamindiamumbaiDisney IndiaMumbai SattaT20 Mumbai LeagueMumbai IndiansMumbai LeagueAll India Majlis E Ittehadul MuslimeenCommunist Party Of India MarxistIndia Today
Open in App

Related Stories

MumbaiMumbai: FIR Filed Over Maharashtra Congress’ Social Media Post Allegedly Inciting Violence

MumbaiMumbai: MNS Workers Protest at Andheri Metro Station, Damage Billboard, Demand Only Marathi Ads

MumbaiMumbai: Bomb Threat at Dadar Railway Station; Police Launch Investigation

MaharashtraMaharashtra Rains: Holiday Declared in All Schools in Palghar on September 29 Due to Heavy Rains

CricketIND vs PAK 2025 Live Streaming: Head-to-Head Record, When and Where to Watch India vs Pakistan Asia Cup Final

Health Realted Stories

HealthRajasthan govt bans cough syrup after patients fall ill in Bharatpur and Sikar

HealthScience innovation accelerates development: MP Minister

HealthCardiology Beyond Stents - How Terna Hospital Manages Heart Failure Holistically

HealthNew blood test to predict risk of liver cirrhosis, cancer within 10 years

HealthIndia must ensure equitable, timely access to lenacapavir to tackle global HIV cases